Of the seven principles set out in the Council for International Organizations of Medical Sciences Working Group (CIOMS) ...

In this week's Pharma Pulse, new Medicaid pricing deals are rumored, employer GLP-1 pullback, and McKesson's $2.25B oncology ...

Cardinal Health's Michelle Britt discusses the policy changes needed to secure independent pharmacy's future, from state advocacy wins to giving pharmacists a seat at the table. Independent pharmacies ...

Virtual care's pre- and post-visit windows offer pharma marketers a more targeted, attentive audience than physical waiting rooms, new research shows, and most brands aren't capitalizing on it yet.

TrumpRx passed its six-month mark with more than 800 listed products and a new commitment from 10 pharmacy benefit managers to surface its cash prices at the point of prescribing.

Similar activation models can strengthen trial recruitment, precision medicine, and population health by converting data into ...

AMCP's Adam Colborn discusses survey findings on TrumpRx's six-month performance, examining payer skepticism about pricing ...

Cardinal Health's Michelle Britt discusses how independent pharmacies are expanding clinical services and leaning on ...

Health care's real challenge isn't more data, it's activation. Arcadia's Sandy Leonard on turning real-world evidence into point-of-care action.

As specialty therapies become more complex, research continues to show that educational, emotional, and practical barriers can influence whether patients initiate therapy and remain engaged over time.

Pharmaceutical Commerce's conversation with Vikram Anand, president of compliance services at EVERSANA, on pharmacovigilance (PV) infrastructure closes with a look at what connect ...

EVERSANA's Vikram Anand explains how disconnected PV systems and manual safety processes can create commercial delays after ...